Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Waters Corporation reported strong fourth quarter and full-year financial results for 2024, reflecting a positive growth trajectory within the life sciences sector.</li><li>The company achieved a 6.4% reported sales growth in the fourth quarter, 8% on a constant currency basis, and attained high single-digit growth in instruments and recurring revenues.</li><li>Earnings per share (EPS) showcased robust growth with a 13% increase to $4.10 on a non GAAP basis, showcasing the firm's resilience amidst challenging economic conditions.</li></ul>

Waters Corporation reported strong fourth quarter and full-year financial results for 2024, reflecting a positive growth trajectory within the life sciences sector.The company achieved a 6.4% reported sales growth in the fourth quarter, 8% on a constant currency basis, and attained high single-digit growth in instruments and recurring revenues.Earnings per share (EPS) showcased robust growth with a 13% increase to $4.10 on a non GAAP basis, showcasing the firm's resilience amidst challenging economic conditions.

Waters Corporation: Regulatory & Application Growth in PFAS Testing Is  Critical Growth Enabler!

<ul><li>Waters Corporation presented its third-quarter 2024 financial results with a mixed set of outcomes, indicating resilience in certain segments despite ongoing market challenges.</li><li>The company's revenue performance exceeded expectations, driven by positive growth across all three geographic regions and specific strength in its pharma and industrial end markets.</li><li>The return to positive sales growth in liquid chromatography (LC) and an uptick in mass spectrometry (Mass Spec) instrument sales highlight a broader recovery context.</li></ul>

Waters Corporation presented its third-quarter 2024 financial results with a mixed set of outcomes, indicating resilience in certain segments despite ongoing market challenges.The company's revenue performance exceeded expectations, driven by positive growth across all three geographic regions and specific strength in its pharma and industrial end markets.The return to positive sales growth in liquid chromatography (LC) and an uptick in mass spectrometry (Mass Spec) instrument sales highlight a broader recovery context.

Waters Corporation’s Bold China Strategy Ignites Surging Demand Amid High-Octane Stimulus! - Major Drivers

<ul><li>Waters Corporation's Second Quarter 2024 financial results reflect a mix of challenges and progress across its various segments.</li><li>The company, a key player in the analytical instruments industry, primarily serves the pharmaceutical, industrial, and academic sectors.</li><li>Notable for its technological investments and strategic acquisitions, Waters reported a 4% decline in sales, including a similar drop in organic constant currency terms.</li></ul>

Waters Corporation's Second Quarter 2024 financial results reflect a mix of challenges and progress across its various segments.The company, a key player in the analytical instruments industry, primarily serves the pharmaceutical, industrial, and academic sectors.Notable for its technological investments and strategic acquisitions, Waters reported a 4% decline in sales, including a similar drop in organic constant currency terms.

Waters Corporation: Enhanced Market Position in China & Expansion in Recurring Revenue Streams Driving Growth! - Major Drivers

<ul><li>Based on Waters Corporation's earnings, the company demonstrated strong operational performance in Q1, although the market conditions were as expected with cautious customer spending and late budget releases.</li><li>Sales landed at the high end of the guidance but declined 7% as reported and 9% in organic constant currency.</li><li>It had a strong start to 2024, with sales coming in at the high end of expectations, reflecting the firm's drive to accelerated the benefits of their science with their innovative portfolio.</li></ul>

Based on Waters Corporation's earnings, the company demonstrated strong operational performance in Q1, although the market conditions were as expected with cautious customer spending and late budget releases.Sales landed at the high end of the guidance but declined 7% as reported and 9% in organic constant currency.It had a strong start to 2024, with sales coming in at the high end of expectations, reflecting the firm's drive to accelerated the benefits of their science with their innovative portfolio.

Waters Corporation: Is It Really Seeing Improving Traction of New Products? - Major Drivers

<ul><li>In terms of positive outcomes, Waters Corporation reported another transformative year, demonstrating its resilience and ability to adapt effectively amidst a backdrop of dynamic market conditions.</li><li>Various innovative products were launched throughout the year, such as the Alliance is next-generation LC platform, building on the successful top line growth delivered in previous years.</li><li>The integration of Wyatt Technology into its portfolio represents a strategic move, bringing with it a new avenue for value creation for shareholders and opening up access to high growth markets.</li></ul>

In terms of positive outcomes, Waters Corporation reported another transformative year, demonstrating its resilience and ability to adapt effectively amidst a backdrop of dynamic market conditions.Various innovative products were launched throughout the year, such as the Alliance is next-generation LC platform, building on the successful top line growth delivered in previous years.The integration of Wyatt Technology into its portfolio represents a strategic move, bringing with it a new avenue for value creation for shareholders and opening up access to high growth markets.

Waters Corporation: How Long Will The Upside From The Continuation of High-Level Trends and Geographical Growth Last? - Major Drivers

United States

Waters Corporation provides high-performance liquid chromatography products and services.  The Company distributes its products worldwide to a wide range of industries such as pharmaceuticals, chemicals, and environmental testing. Waters also designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments and related software products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Waters Corp (WAT US)

Waters Corporation: Regulatory & Application Growth in PFAS Testing Is Critical Growth Enabler!

Waters Corporation reported strong fourth quarter and full-year financial results for 2024, reflecting a positive growth trajectory within the...

Baptista Research

Waters Corporation’s Bold China Strategy Ignites Surging Demand Amid High-Octane Stimulus! - Major Drivers

Waters Corporation presented its third-quarter 2024 financial results with a mixed set of outcomes, indicating resilience in certain segments...

Baptista Research

Waters Corporation: Enhanced Market Position in China & Expansion in Recurring Revenue Streams Driving Growth! - Major Drivers

Waters Corporation's Second Quarter 2024 financial results reflect a mix of challenges and progress across its various segments. The company, a...

Baptista Research

Waters Corporation: Is It Really Seeing Improving Traction of New Products? - Major Drivers

Based on Waters Corporation's earnings, the company demonstrated strong operational performance in Q1, although the market conditions were as...

Baptista Research

Waters Corporation: How Long Will The Upside From The Continuation of High-Level Trends and Geographical Growth Last? - Major Drivers

In terms of positive outcomes, Waters Corporation reported another transformative year, demonstrating its resilience and ability to adapt...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)